| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |